Drug intelligence / Profile preview

calcium carbonate + cholecalciferol (Cipla)

Development stage
Unknown
Lead developer
Cipla
Modality
Small Molecules
Administration
Oral
01

Overview

Cipcal is a widely used nutritional supplement marketed by Cipla, primarily indicated for the prevention and treatment of calcium and vitamin D3 deficiencies. It typically contains a combination of calcium carbonate and cholecalciferol (vitamin D3). Calcium is essential for maintaining bone density and structural integrity, while vitamin D3 facilitates the intestinal absorption of calcium and regulates bone mineralization. It is commonly prescribed for conditions such as osteoporosis, osteomalacia, and during pregnancy or lactation when nutritional requirements are increased. The product is available in various strengths and formulations, including tablets and suspensions, to cater to different patient needs.

Brand names
CipcalCipcal 500Cipcal500Cipcal-500Cipcal DCipcal HDCipcal 250Cipcal250Cipcal-250
Other names
calcium carbonate + vitamin D3calcium + cholecalciferol
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on calcium carbonate + cholecalciferol (Cipla).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calcium carbonate + cholecalciferol (Cipla).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call